Delivery Order SPE2DB22D3004-SPE2DB24FPK14
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products. The contract has a potential value of $5,290.80 and a completion date of March 19, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies. The contract has a potential value of $21,163.20 and a period of performance through March 28, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is responsible for delivering the pharmaceutical products to DLA's...
- The Defense Logistics Agency (DLA) has awarded a $21,163.20 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML. The contract has a completion date of February 26, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that provides pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense....
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,527.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary contract vehicle for the company to deliver pharmaceutical products...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML. The potential value of this order is $5,290.80, with a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which is not designated as a set-aside contract. This award is part of...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $2,116.32 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4563681046 - GEL-ONE 30 MG/3 ML SYRINGE 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the company to deliver pharmaceutical products and...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $10,228.88 contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with a completion date of May 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025 for a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for a specialty pharmaceutical product, GEL-ONE 30 MG/3 ML SYRINGE 3ML, with a ceiling value of $3,527.20. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical with a potential value of $3,527.20. The order is for the supply of 4,563,677,953 units of the pharmaceutical product GEL-ONE 30 MG/3 ML SYRINGE 3ML. The contract has a completion date of March 1, 2024 and was awarded on February 8, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp...
- This delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $7,054.40 firm fixed price contract is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML pharmaceutical products to support military treatment programs and facilities. The contract has a completion date of February 1, 2024. Amerisourcebergen Drug Corp has a track record...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPK14Delivery Order
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for GEL-ONE 30 MG/3 ML SYRINGE 3ML. The potential value of this contract is $1,763.60 and the completion date is March 12, 2024. Amerisourcebergen Drug Corp provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense, through indefinite delivery contracts (IDCs) with DLA. This specific delivery order is part of a larger IDC awarded solely to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 2/20/24 |